Rohm Labs Clenbuterol 40mcg x 100 tablets

£37.00

Description
Reviews (0)

Rohm Labs Clenbuterol 40mcg x 100 Tablets: Premium Beta-2 Agonist Research Standard

Rohm Labs Clenbuterol 40mcg x 100 tablets delivers a precise oral formulation of Clenbuterol Hydrochloride, a potent beta-2 adrenergic receptor agonist widely utilized in respiratory and metabolic research. Originally developed as a bronchodilator for treating asthma and obstructive pulmonary conditions, this compound has gained significant attention for its thermogenic and lipolytic properties. Each package contains 100 tablets dosed at 40mcg, providing substantial supply for extended research protocols examining metabolic rate enhancement, fat oxidation, and sympathomimetic effects. The 40mcg concentration enables accurate titration, supporting studies requiring gradual dose escalation and precise physiological control.

Clenbuterol distinguishes itself through high selectivity for beta-2 adrenergic receptors compared to non-selective beta agonists. This selectivity minimizes cardiac beta-1 stimulation while maximizing metabolic and bronchodilatory effects. Researchers utilize Rohm Labs Clenbuterol 40mcg x 100 tablets for examining lipolysis mechanisms, thermogenesis, skeletal muscle preservation during caloric restriction, and respiratory function enhancement. The compound’s ability to increase metabolic rate without significant androgenic activity makes it valuable for body composition and metabolic disease research.

The 40mcg tablet strength represents a standard research unit, allowing for flexible dosing protocols. Typical research applications implement gradual titration from 20–40mcg daily, escalating based on subject tolerance and observed metabolic response. The extended 100-tablet supply supports multi-week protocols examining chronic beta-2 receptor stimulation and adaptation phenomena.

Key Features

Rohm Labs Clenbuterol 40mcg x 100 tablets offers specific advantages for advanced research applications:

High Beta-2 Selectivity: Minimizes cardiac beta–1 stimulation while maximizing metabolic effects.
Potent Thermogenic Activity: Significant elevation of metabolic rate and caloric expenditure.
Lipolytic Enhancement: Direct stimulation of fat cell lipolysis and fatty acid mobilization.
Bronchodilatory Effect: Relaxation of airway smooth muscle supporting respiratory research.
Anti-Catabolic Properties: Preservation of lean tissue during caloric deficit conditions.
Precise Microdosing: 40mcg tablets enable accurate titration and protocol adjustment.
Extended Supply: 100-tablet format supports longer research timelines without resupply.
Verified Purity Standards: Manufactured under strict pharmaceutical protocols with independent batch testing.

Product Specifications

Product Name: Rohm Labs Clenbuterol
Active Ingredient: Clenbuterol Hydrochloride
Chemical Classification: Beta-2 Adrenergic Receptor Agonist / Sympathomimetic Amine
Dosage Strength: 40mcg per tablet
Pack Size: 100 tablets
CAS Number: 21898-19-1
Molecular Formula: C12H18Cl2N2O · HCl
Appearance: White to off-white round tablets
Standard Protocol: 20-120mcg daily, titrated gradually over 2-week cycles
Storage Requirements: Store at 15°C-25°C; protect from light, moisture, and heat
Shelf Life: 3 years from manufacture date (as indicated on packaging)
Legal Status: Banned for human use in many jurisdictions / Veterinary use only in some regions

Mechanism of Action

Rohm Labs Clenbuterol 40mcg x 100 tablets operates through selective adrenergic receptor activation:

Beta-2 Receptor Agonism: High-affinity binding to beta-2 adrenergic receptors on cell membranes.
Adenylate Cyclase Activation: Stimulates cAMP production, triggering downstream metabolic cascades.
Lipolysis Stimulation: Activates hormone-sensitive lipase, promoting triglyceride breakdown in adipocytes.
Thermogenesis Induction: Increases basal metabolic rate through mitochondrial uncoupling protein activation.
Bronchial Relaxation: Smooth muscle relaxation in respiratory airways via beta-2 mediated signaling.
Protein Synthesis: Anabolic effects in skeletal muscle through mTOR pathway activation.

Metabolic Impact

Research utilizing Rohm Labs Clenbuterol 40mcg x 100 tablets reveals significant physiological effects:

Metabolic Rate Elevation: 10-20% increase in basal metabolic expenditure.
Fat Oxidation: Enhanced lipolysis and fatty acid utilization for energy production.
Body Temperature Increase: Elevated core temperature through thermogenic mechanisms.
Cardiovascular Stimulation: Increased heart rate and blood pressure at higher doses.
Glycogenolysis: Enhanced hepatic glucose output and muscle glycogen utilization.
Muscle Preservation: Anti-catabolic effects maintaining lean tissue during caloric restriction.
Receptor Desensitization: Beta-2 downregulation with chronic use requiring cycling protocols.

Where to Buy

Acquiring genuine Rohm Labs Clenbuterol 40mcg x 100 tablets requires sourcing from authorized distributors.

Authorized Suppliers Only: Purchase exclusively from verified Rohm Labs distributors with documented authorization.
Batch Verification: Verify unique batch codes through official Rohm Labs channels before use.
Visual Inspection: Authentic packaging features professional labeling, intact seals, and uniform tablets free of defects.
Avoid Unverified Sources: Do not purchase from social media, underground forums, or vendors lacking proof of authenticity.

Conclusion

Rohm Labs Clenbuterol 40mcg x 100 tablets represents a powerful research tool for investigators examining beta-2 adrenergic receptor physiology, thermogenesis, and metabolic enhancement. The 40mcg precise dosing and extended 100-tablet supply support sophisticated protocols examining lipolysis, body composition, and respiratory function. The high beta-2 selectivity distinguishes Clenbuterol from non-selective sympathomimetics, enabling metabolic research with reduced cardiac complications. However, the potent stimulatory nature demands careful titration and monitoring of cardiovascular parameters, core temperature, and electrolyte balance. The well-documented phenomenon of receptor desensitization necessitates structured cycling protocols to maintain efficacy. Researchers must account for potential tachycardia, tremors, and hypokalemia in study design.